|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| C12N 15/11 | (2006.01) | ||
| C12Q 1/68 | (2018.01) | ||
| C07K 16/18 | (2006.01) | ||
| C40B 40/06 | (2006.01) |
| (11) | Number of the document | 3034513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15196994.6 |
| Date of filing the European patent application | 2012-07-12 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161506749 P | 2011-07-12 | US |
| (72) |
SIMARD, John, US
|
| (73) |
XBiotech, Inc,
1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9,
CA
|
| (54) | IDENTIFYING AFFINITY-MATURED HUMAN ANTIBODIES |
| IDENTIFYING AFFINITY-MATURED HUMAN ANTIBODIES |